Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis.

Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis.

Item
http://www.wikidata.org/entity/Q35186537
Pharmacotherapy of end-stage renal disease.Pioglitazone improves fat distribution, the adipokine profile and hepatic insulin sensitivity in non-diabetic end-stage renal disease subjects on maintenance dialysis: a randomized cross-over pilot study.Comparison of the Effects of Pioglitazone versus Placebo when Given in Addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus Requiring Hemodialysis: Results from the PIOren Study.The effects of thiazolidinediones on blood pressure levels - a systematic review.Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential.A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients.Thiazolidinedione safety.Use of dipeptidyl peptidase-4 inhibitors for the treatment of patients with type 2 diabetes mellitus and chronic kidney disease.Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease.Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis.
P2860

Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis.

Item
http://www.wikidata.org/entity/Q35186537
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis.
@ast
Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis.
@en
type
label
Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis.
@ast
Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis.
@en
prefLabel
Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis.
@ast
Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis.
@en
P2093
P2860
P304
P31
P356
10.1592/PHCO.23.7.861.32727
P407
P433
P478
P577
P698